secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001437749-24-006900
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Monopar posts radiopharma presentation on investor website
----------------------------------------------------------

- Presentation posted on March 7, 2024 under Investor section at monopartx.com.
- Focus on radiopharma; no financial details or business updates provided.
- No other material disclosures in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924006900/0001437749-24-006900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774924006900/mnpr20240305_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer